Total Valuation
Medicalgorithmics SA has a market cap or net worth of zł264.99M. The enterprise value is zł291.63M.
Market Capzł264.99M
Enterprise Valuezł291.63M
Share Statistics
Medicalgorithmics SA has 10,453,389 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,453,389
Owned by Insiders―
Owned by Institutions0.09%
Financial Efficiency
Medicalgorithmics SA’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -11.38%.
Return on Equity (ROE)-0.18
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-11.38%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee284.27K
Profits Per Employee-107.19K
Employee Count109
Asset Turnover0.28
Inventory Turnover6.70
Valuation Ratios
The current PE Ratio of Medicalgorithmics SA is ―. Medicalgorithmics SA’s PEG ratio is 1.03.
PE Ratio―
PS Ratio10.79
PB Ratio5.18
Price to FCF-156.56
Price to Operating Cash Flow40.27
PEG Ratio1.03
Income Statement
In the last 12 months, Medicalgorithmics SA had revenue of 30.98M and earned -11.68M in profits. Earnings per share was -1.17.
Revenue30.98M
Gross Profit-5.56M
Operating Income-11.47M
Pretax Income-11.70M
Net Income-11.68M
EBITDA-6.83M
Earnings Per Share (EPS)-1.17
Cash Flow
In the last 12 months, operating cash flow was 6.27M and capital expenditures -4.06M, giving a free cash flow of 2.21M billion.
Operating Cash Flow6.27M
Free Cash Flow2.21M
Free Cash Flow per Share0.21
Dividends & Yields
Medicalgorithmics SA pays an annual dividend of zł1.42, resulting in a dividend yield of 1.11%
Dividend Per Sharezł1.42
Dividend Yield1.11%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-26.52%
50-Day Moving Average26.35
200-Day Moving Average28.30
Relative Strength Index (RSI)47.04
Average Volume (3m)18.74K
Important Dates
Medicalgorithmics SA upcoming earnings date is Nov 26, 2026, TBA (Confirmed).
Last Earnings DateSep 29, 2026
Next Earnings DateNov 26, 2026
Ex-Dividend Date―
Financial Position
Medicalgorithmics SA as a current ratio of 1.30, with Debt / Equity ratio of 42.51%
Current Ratio1.30
Quick Ratio0.88
Debt to Market Cap0.07
Net Debt to EBITDA-2.90
Interest Coverage Ratio-5.60
Taxes
In the past 12 months, Medicalgorithmics SA has paid -23.00K in taxes.
Income Tax-23.00K
Effective Tax Rate<0.01
Enterprise Valuation
Medicalgorithmics SA EV to EBITDA ratio is -51.87, with an EV/FCF ratio of -165.85.
EV to Sales11.43
EV to EBITDA-51.87
EV to Free Cash Flow-165.85
EV to Operating Cash Flow-194.43
Balance Sheet
Medicalgorithmics SA has zł2.47M in cash and marketable securities with zł26.84M in debt, giving a net cash position of -zł24.38M billion.
Cash & Marketable Securitieszł2.47M
Total Debtzł26.84M
Net Cash-zł24.38M
Net Cash Per Share-zł2.33
Tangible Book Value Per Share-zł2.28
Margins
Gross margin is 28.76%, with operating margin of -37.02%, and net profit margin of -37.71%.
Gross Margin28.76%
Operating Margin-37.02%
Pretax Margin-37.76%
Net Profit Margin-37.71%
EBITDA Margin-22.04%
EBIT Margin-37.02%
Analyst Forecast
The average price target for Medicalgorithmics SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast54.46%
EPS Growth Forecast47.91%